# Dataset report: CD010966_pub4_data

Generated: 2026-01-02 16:05:54

## Mismatch summary
- Analyses with mismatches: 6
- Any mismatch: 6 (1)
- Direction mismatch: 4 (0.667)
- Significance mismatch: 5 (0.833)

## Row-level data signals (mismatch rows only)
- Double-zero rows: 267
- All-event rows: 5
- Sparse-event rows (<5 total): 768
- Any zero rows: 647
- Invalid binary rows: 0
- Event rate (valid rows): 0.0865

## Mismatch types
- direction_and_significance: 3
- direction_only: 1
- significance_only: 2

## Top direction mismatches (by |log OR|)
- 3::overall | Adverse effects: 200 mg lumacaftor group versus placebo at up to 1 month | log_or=-0.156 | rd=0.003 | k=121
- 2::overall | Adverse effects: 100 mg and 200 mg lumacaftor groups (combined data) versus placebo at up to 1 month | log_or=-0.102 | rd=0.029 | k=141
- 5::overall | Sweat chloride concentration (change from baseline at up to 1 month) [mmol/L] | log_or=-0.099 | rd=0.024 | k=112
- 4::overall | Adverse effects requiring study drug discontinuation at up to 1 month | log_or=-0.078 | rd=0.017 | k=451
